Cardiovascular Diseases Research federal funding in FY2026

Cardiovascular Diseases Research overlapping FY2026 — CFDA 93.837

The pair is Cardiovascular Diseases Research × FY2026. $392,087,776.12 is the obligation aggregate for rows that carry both CFDA 93.837 and fiscal year 2026 on the yearlyTrend table. The FY2026 obligation $392,087,776.12 is 1.6% of the CFDA program total of $24,340,828,120.12. This page does not invent the other fiscal-year rows that sit outside FY2026 on Cardiovascular Diseases Research. Correlation is not causation: the join does not prove that FY2026 caused Cardiovascular Diseases Research activity, only that USAspending coded the two keys together. It is not a university ranking or a named cardiology-lab list.

SpendingVault indexes the cell from USAspending.gov. The catalog title on the program side is CARDIOVASCULAR DISEASES RESEARCH. The year on the other side is federal fiscal year 2026. Neither label is a contractor, a place of performance, or an awarding-agency code — this packet publishes no awarding agency and no named recipients. Cite $392,087,776.12 as obligations on the Cardiovascular Diseases Research–FY2026 pair. One hundred seventy-six FY2026 awards on $392 million sit far below the program-wide 11,285-award extract; other years stay on the program hub.

CFDA 93.837 as the Cardiovascular Diseases Research side

CFDA 93.837 is the Catalog of Federal Domestic Assistance identifier for Cardiovascular Diseases Research. The program-wide obligation total in this extract is $24,340,828,120.12 across 11,285 awards. That figure is a program rollup, not a second headline for the FY2026 cell unless the two amounts match. Do not treat $24,340,828,120.12 as cash Treasury already sent. Lab names, protocol IDs, and enrollment totals are unpublished on this packet.

Open CFDA 93.837 at /programs/93.837/ for the program hub. That page is not this join: it can include other fiscal years if the extract lists them, and it is still obligations rather than outlays. This ties page stays on CFDA 93.837 in FY2026 only.

FY2026 as the cardiovascular research yearlyTrend cell

Federal fiscal year 2026 is the time key on this yearlyTrend row. The year hub FY2026 federal spending at /fiscal-years/2026/ rolls up every program that year in the index, not only Cardiovascular Diseases Research. Reading $392,087,776.12 as all FY2026 federal obligations would over-read this cell. The join is one CFDA inside one fiscal year, not a Budget Appendix score.

176 FY2026 awards as a CFDA table, not a trial census

The extract lists 176 awards on the Cardiovascular Diseases Research × FY2026 table. That is an award-record count for this yearlyTrend cell, not a census of heart-disease studies. Unique recipients are unpublished. Modifications can add rows without naming a new organization. Dividing $392,087,776.12 by 176 is not published here as a typical award size, because the packet does not say the rows are comparable. The program-wide award count is 11,285, a different denominator.

Trial rankings this 93.837–FY2026 join cannot support

An obligation is a legal commitment. An outlay is a payment. $392,087,776.12 is the former. Citing it as cash already cleared on Cardiovascular Diseases Research in FY2026 over-reads the field. The join cannot say that Cardiovascular Diseases Research expanded in FY2026 because of a policy success metric this packet omits. Keep $392,087,776.12 labeled as Cardiovascular Diseases Research obligations in fiscal year 2026.

Budget justifications, program evaluations, and press releases answer other questions. They are not the source of this cell. If a chart mixes a different CFDA with FY2026 or a different fiscal year with Cardiovascular Diseases Research, the chart has left this join. Lab names, protocol IDs, and enrollment totals are unpublished on this packet.

Hubs for CFDA 93.837 × FY2026

Open /programs/93.837/ for CFDA 93.837, /fiscal-years/2026/ for FY2026 federal spending, /programs/ (All programs) for other catalog lines, and /ties/ (All spending ties) for other pairs. None of those links convert this cell into a university ranking or a named cardiology-lab list, into outlays this packet omits, or into a contractor list. Cite both sides: Cardiovascular Diseases Research and FY2026, $392,087,776.12, USAspending.gov, obligations only.

Questions

How much did Cardiovascular Diseases Research obligate in FY2026?

USAspending.gov records $392,087,776.12 in Cardiovascular Diseases Research obligations for fiscal year 2026 (CFDA 93.837) across 176 awards. That is an obligation aggregate for the pair, not an outlay and not the program-wide $24,340,828,120.12.

Is Cardiovascular Diseases Research in FY2026 cash already paid?

No. $392,087,776.12 is an obligation sum, not an outlay. Payments from the Treasury can lag or differ. This packet has no outlay total for Cardiovascular Diseases Research in FY2026. Original filings remain on USAspending.gov. Keep both the CFDA number and the fiscal year in the citation.

Does 176 awards mean 176 heart-disease studies in FY2026?

No. 176 is an award-record count for the FY2026 cell, not a census of heart-disease studies. Unique recipients and places of performance are unpublished. The program-wide count is 11,285. Original filings remain on USAspending.gov. Keep both the CFDA number and the fiscal year in the citation.

Which pages parent Cardiovascular Diseases Research and FY2026?

/programs/93.837/ is the program parent. /fiscal-years/2026/ is the FY2026 parent. /programs/ lists programs. /ties/ lists other pairs. Prefer those tables after later ingests; this page quotes Cardiovascular Diseases Research × FY2026 at $392,087,776.12. Original filings remain on USAspending.gov.